Obizur Kit
NDC 0944-5001
Product Information
Obizur (antihemophilic factor (recombinant), porcine sequence) is a BLA-approved product labeled by Takeda Pharmaceuticals America, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a kit. This product entry covers the primary NDC 0944-5001 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 0944-5001?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- OBIZUR (NDC 0944-5011)
- SUSOCTOCOG ALFA (UNII: 6892UQT2GK)
- SUSOCTOCOG ALFA (UNII: 6892UQT2GK) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- OBIZUR (NDC 0944-5011)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- CALCIUM CHLORIDE (UNII: M4I0D6VV5M)
- SUCROSE (UNII: C151H8M554)
- TROMETHAMINE (UNII: 023C2WHX2V)
- TROMETHAMINE HYDROCHLORIDE (UNII: 383V75M34E)
- SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- STERILE WATER (NDC 0944-0011)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1593154 - antihemophilic factor, porcine B-domain truncated recombinant 1 UNT Injection
- RxCUI: 1593154 - factor VIII, porcine B-domain truncated recombinant 1 UNT Injection
- RxCUI: 1593156 - OBIZUR 1 UNT Injection
- RxCUI: 1593156 - antihemophilic factor, porcine B-domain truncated recombinant 1 UNT Injection [Obizur]
- RxCUI: 1593156 - Obizur 1 UNT Injection
* Please review the full disclaimer at the bottom of this page.